Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income $ 123,636 $ 109,244
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of property, equipment and capitalized software 37,617 31,932
Amortization of intangible assets 6,182 4,365
Deferred income taxes (8,921) (577)
Stock compensation expense 12,785 12,809
Changes in assets and liabilities:    
Accounts receivable-billed and billable (81,430) (1,362)
Accounts receivable - unbilled 2,209 3,280
Prepaid expenses and other current assets (3,496) (1,343)
Deferred contract costs (7,390) 556
Accounts payable and accrued liabilities 45,064 (5,686)
Accrued compensation and benefits (4,546) 2,510
Deferred revenue 32,424 88
Income taxes 37,476 6,162
Other assets and liabilities (10,630) 3,172
Cash provided by operating activities 180,980 165,150
Cash flows from investing activities:    
Purchases of property and equipment (68,243) (18,389)
Capitalized software costs (4,924) (9,177)
Acquisition of businesses, net of cash acquired (289,612) (2,670)
Proceeds from note receivable 406 350
Cash used in investing activities (362,373) (29,886)
Cash flows from financing activities:    
Cash dividends paid (8,966) (9,181)
Repurchases of common stock (32,616) (59,354)
Tax withholding related to RSU vesting (12,451) (14,681)
Expansion of credit facility (1,444)  
Borrowings under credit facility 255,993 15,000
Repayment of credit facility and long-term debt (90,112) (15,122)
Tax benefit/(provision) due to option exercises and restricted stock units vesting (1,208) 2,925
Stock option exercises 521 1,145
Cash provided by/ (used in) financing activities 109,717 (79,268)
Effect of exchange rate changes on cash and cash equivalents (4,559) 1,329
Net increase/(decrease) in cash and cash equivalents (76,235) 57,325
Cash and cash equivalents, beginning of period 158,112 125,617
Cash and cash equivalents, end of period $ 81,877 $ 182,942